CompletedNot Applicable

Exposure, D-cycloserine Enhancement, and Functional Magnetic Resonance Imaging (fMRI) in Snake Phobics

United States20 participantsStarted 2010-07

Plain-language summary

The aim of the present study is to determine whether people receiving d-cycloserine and exposure therapy show different brain reactions to symptom provocation compared to people receiving placebo and exposure therapy.

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Primary diagnosis of specific phobia (snakes) Exclusion Criteria: * History of psychosis, obsessive-compulsive disorder, or mania * Recent substance abuse or suicidality * Previous receipt of study treatments

What they're measuring

Snake Questionnaire (SNAQ)

Timeframe: 2 weeks

Trial details

NCT IDNCT01450306

SponsorHartford Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2011-12

Results submitted2012-05-24

View on ClinicalTrials.gov More Specific Phobia trials